Bernard H. Bochner

Active 1992–2025

Also published as
Bernard H Bochner
115
Papers
35,844
Citations
81
h-index
111
i10-index

Citations

Citations per year for Bernard H. Bochner1945: 1 citations1952: 1 citations1976: 1 citations1977: 1 citations1992: 3 citations1995: 1 citations1996: 3 citations1997: 7 citations1998: 10 citations1999: 8 citations2000: 23 citations2001: 21 citations2002: 29 citations2003: 58 citations2004: 71 citations2005: 57 citations2006: 89 citations2007: 106 citations2008: 66 citations2009: 108 citations2010: 120 citations2011: 146 citations2012: 136 citations2013: 140 citations2014: 203 citations2015: 201 citations2016: 250 citations2017: 280 citations2018: 362 citations2019: 1,297 citations2020: 1,685 citations2021: 1,381 citations2022: 1,086 citations2023: 857 citations2024: 1,274 citations2025: 562 citations2026: 23 citations1946–1951: no citations, so these years are not shown1953–1975: no citations, so these years are not shown1978–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,060 citing papers, 27.1% of this breakdownChina: 1,823 citing papers, 12.2% of this breakdownItaly: 849 citing papers, 5.7% of this breakdownGermany: 811 citing papers, 5.4% of this breakdownUnited Kingdom: 797 citing papers, 5.3% of this breakdownCanada: 646 citing papers, 4.3% of this breakdownFrance: 559 citing papers, 3.7% of this breakdownJapan: 505 citing papers, 3.4% of this breakdownSpain: 490 citing papers, 3.3% of this breakdownNetherlands: 438 citing papers, 2.9% of this breakdownSwitzerland: 351 citing papers, 2.3% of this breakdownAustria: 314 citing papers, 2.1% of this breakdown
0%27.1%Other 22.3%

Fields

  • Medicine70.7%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Immunology and Microbiology2.9%
  • Computer Science1.1%
  • Engineering0.4%
  • Neuroscience0.2%
  • Other1.2%

Topics

  • Bladder and Urothelial Cancer Treatments12.2%
  • Urinary and Genital Oncology Studies6.6%
  • Cancer Immunotherapy and Biomarkers6.6%
  • Cancer Genomics and Diagnostics5.3%
  • Ferroptosis and cancer prognosis3.3%
  • Epigenetics and DNA Methylation2.4%
  • Other63.6%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 cited by 3,517

  3. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663

  4. Comprehensive molecular characterization of urothelial bladder carcinoma Open

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David J. Kwiatkowski, Andrew D. Cherniack, Weiguo Jian, Chandra Sekhar Pedamallu, Richard C. Gibbs, Seth P. Lerner, Kristian Cibulskis, Patricia Garrido Castro, Andrey Sivachenko, Chip Stewart, Michael S. Lawrence, Whitney D. McClenden, Margaret Morgan, Richard C. Gibbs, Scott L. Carter, Chad J. Creighton, Lawrence A. Donehower, Chad J. Creighton, C. Smith, Ami S. Bhatt, Trevor Pugh, Gordon Saksena, Lee Lichtenstein, Michael S. Lawrence, Carrie Sougnez, Kristian Cibulskis, Daniel DiCara, Petar Stojanov, Steven E. Schumacher, Doug Voet, Yingchun Liu, Jaegil Kim, Petar Stojanov, Doug Voet, Pei Lin, Hailei Zhang, Scott L. Carter, Scott Frazer, Michael S. Noble, Daniel DiCara, Lihua Zou, Bernard H. Bochner, Nils Gehlenborg, Ilana R. Garcia-Grossman, David I. Heiman, Juok Cho, Rameen Beroukhim, Dmitry A. Gordenin, David J. Kwiatkowski, Ami S. Bhatt, Andrey Sivachenko, Joonil Jung, Chip Stewart, Andrew D. Cherniack, Samuel S. Freeman, Eric Lander, Michael S. Noble, Tod D. Casasent, David J. Van Den Berg, David J. Kwiatkowski, Nikolaus Schultz, David J. Kwiatkowski, Jianjiong Gao, Anders Jacobsen, B. Arman Aksoy, Ami S. Bhatt, Petar Stojanov, Chandra Sekhar Pedamallu, Rameen Beroukhim, William Lee and 194 more - Nature, Nat. 2014 cited by 3,086

  5. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)

    Authors: , , , , , , , , , , , , , , , , , - European Urology 2018 cited by 636

  6. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

    Authors: , , , , , , , , , , , , , - The Journal of Urology 2017 cited by 940

  7. The mechanism of action of BCG therapy for bladder cancer—a current perspective

    Authors: , , - Nature Reviews Urology 2014 cited by 709

  8. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2001 cited by 3,539

  9. Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stacey Gabriel, Alan D. D’Andrea, Levi A. Garraway, Jonathan E. Rosenberg - Cancer Discovery 2014 cited by 624

  10. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 cited by 69

  11. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , - European Urology 2017 cited by 372

  12. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Authors: , , , , , , , , , , - European Urology 2008 cited by 1,399

  13. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan E. Rosenberg, Min Yuen Teo, Dean F. Bajorin - Journal of Clinical Oncology 2023 cited by 105

  14. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun Vasant Balar, Amir Mortazavi, Jonathan E. Rosenberg - Journal of Clinical Oncology 2022 cited by 99

  15. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    Authors: , , , , , , , - Cancer 2008 cited by 357

  16. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 cited by 70

  17. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort

    Authors: , , , , , , , , , , , - European Urology 2021 cited by 102

  18. Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder

    Authors: , , , , , , - Cancer 2006 cited by 433

  19. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 283

  20. Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 cited by 67

  21. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , - European Urology 2014 cited by 597

  22. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , - European Urology Oncology 2020 cited by 171

  23. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 279

  24. Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 131